Abstract
Introduction
''Memory-like'' regulatory CD8 + T cells have witnessed a renaissance as suppressive immunoregulators in pathologies such as autoimmune and infectious diseases and cancer [1, 2, 3] . Impaired numbers and functions of regulatory CD8 + T cells (CD8 + Tregs) have been defined in various experimental models of autoimmunity. Multiple subsets of CD8 + T cells, naturally present in non-immunized mice or induced, have been described to be suppressive [4] and to act through different mechanisms such as secretion of inhibitory cytokines, cytokine-deprivation, granzyme A/B-perforin-induced cytotoxicity and inhibition of dendritic cell functions [5, 6, 7] . For instance, CD8 + CD28 2 Tregs, induced in vitro by antigen stimulation, express classical regulatory markers such as Foxp3, GITR, CTLA-4, CD25, CD103, CD62L and 4-1BB [8] and produce the immunosuppressive cytokines IL-10 and TGF-b [2, 9] . Their suppressive activities are MHC class Irestricted, contact-dependent and require the presence of antigen presenting cells. Transfer of CD8 + CD28 2 Tregs into CD8 + T celldeficient mice significantly suppressed experimental autoimmune encephalomyelitis (EAE) [2] .
Antigenic stimulation induces CD8 + CD103 + Tregs in mice and humans. These cells express CD28, lack CD25, Foxp3, GITR, CTLA-4 and LAG-3, and the expression of CD103 is enhanced by TGF-b [10, 11] . CD8 + CD103 + Tregs produce IL-10 and TGF-b and require cell contact and IFN-c secretion for their inhibitory effect [12] . Furthermore, Qa-1-restricted CD8 + Tregs inhibit the development of a lupus-like autoimmune disorder and EAE [13, 14] . Analysis of the phenotype of Qa-1-restricted CD8 + Tregs indicated the expression of CD44, CD122 and Ly-49 [15] . Like induced CD8
+ CD25 + Tregs [6, 16] also Qa-1-restricted CD8
+
Tregs require perforin and IFN-c for their suppressive activity [17] . In mice IL-10 secreting CD8 + CD122 + Tregs were found in the periphery of unimmunized mice and are proposed to be the counterpart of human CD8 + CXCR3 + T cells [18] . Their protective role has been shown in the murine EAE [19] and in a CD4
+ T cell-induced colitis model [20] . Despite of numerous reports on the existence of CD8 + Tregs their functional characteristics, marker profile and mechanisms of action still remain to be defined.
It is increasingly evident that purigenic signaling mediated by ectonucleotidases such as CD39, CD73 and CD38 strongly influences the adaptative immunity [21] . Indeed, the CD39 nucleoside triphosphate diphosphohydrolase together with CD73, ecto-59-nucleotidase, generate pericellular adenosine from extracellular nucleotides which is required for CD4 + CD25 + Foxp3 + Tregs-mediated immune suppression [22] . CD38 ectonucleotidase is a multifunctional ectoenzyme, that is able to transform nicotinamide adenosine diphosphate ribose (NAD+) into ADPribose (ADPR) and cADP-ribose (cADPR), but also hydrolyses cADPR into ADPR [23, 24] . It is a type II glycosylated membrane protein, ubiquitously expressed on both hematopoietic and nonhematopoietic tissues, which regulates Ca 2+ mobilization [25] . Recently, CD38 has been found to be associated with regulatory T cell activities. Herein, murine CD45RB low memory CD4 + T cells expressing CD38 inhibit anti-CD3-induced T cell proliferation and cytokine secretion [26] . In the absence of CD38, NOD mice develop accelerated autoimmune diabetes, and CD38 2/2 mice show an impaired regulatory T cell development [27] . CD38 has been shown to compete with ADP-ribosyltransferase 2 (ART2) for NAD, and in this case, CD38 deficiency in Tregs is associated with NAD-induced T cell apoptosis [27, 28] . High expression of CD38 on Foxp3
+ CD4 + T cell subpopulations correlates with strongest regulatory properties of CD4 + regulatory T cells [29] . In humans, the detection of anti-CD38 autoantibodies is associated with Type I diabetes, chronic autoimmune thyroiditis or Graves' disease [30, 31] . CD38 expression is tightly regulated during lymphocyte development and activation in both humans and mice. While in humans CD38 expression is high on mature thymocytes and activated T cells but low on resting naive T cells [32] , CD38 expression in mice is restricted to a ab TCR +
CD4
2 CD8 2 subset of thymocytes but at very low levels on resting T lymphocytes [33] . Interestingly, a subset of activated and memory T lymphocytes expressing CD38 is characterized by low proliferating activity but enhanced IL-2 and IFN-c production capacity [34] .
Unimmunized young mice generate and maintain ''memorylike'' CD8 + T cells of unknown antigen encounter history. However, their immune functions, the heterogeneity of their phenotype and the mechanisms of action are still poorly understood. In this study, we demonstrate that the ectonucleotidase CD38 is highly expressed on memory-like CD8
high T cells exhibited suppressive properties which depend on IFN-c secretion. We therefore propose that CD8 + CD38 high T cells potentially contribute to T cell homeostasis control.
Results

CD38 is Expressed on Memory-like CD8
+ T Cells CD38 has long been considered an activation marker, however high expression of CD38 on CD4 + T cell subpopulations has been associated with regulatory properties [26, 29] . More recently, CD38 has been described to be part of the Treg transcriptional signature [35, 36] . Furthermore, it has been shown that CD38-deficient NOD mice display a marked reduction in viable CD8
+ T cells but a significant increase in b-cell-autoreactive CD8 + T cells together with an accelerated autoimmune diabetes [27] . We have analysed the CD38 expression on CD8 + T cells from spleens and lymph nodes (LN) ( Figure 1A ). On average, 8.4%61.5 of spleen (n = 6) and 5.4%60.7 of LN (n = 7) CD8 + T cells are CD38 high ( Figure 1A ).
Resting CD8
+ T cells are heterogeneously positive for CD38. We have focussed on the CD8 +
CD38
high T cell population. We compared the phenotype of these cells to CD8 + CD38 2 T cells using a panel of markers for T cell activation and memory function, cytokine receptors and natural killer cell (NK) markers. High levels of CD38 expression correlate with high CD122 and CD44 and low CD103 expression ( Figure 1B) 
IL-15 Promotes Expansion and Survival of CD8 + CD38 high T Cells
Common gamma chain cytokines contribute to maintenance of memory CD8
+ T cell homeostasis. To investigate the importance of IL-15 for survival and proliferation of CD8 + CD38 high T cells, the subset was cell-sorted by FACS to a purity of .91% ( Figure 2A ) and cultured either in medium alone or with IL-15 or IL-2. In the presence of IL-15, more than 90% of CD8 + CD38 high T cells divided at 72h, while only 34% of CD8 + CD38 2 T cells were detected to proliferate ( Figure 2B ). In contrast, supplementation with IL-2 showed a rather low proproliferative effect. Both CD8 + T cell subsets proliferated to a high extent in response to TCR-engagement ( Figure 2B, 
CD38
2 T cells had a minimal effect on CD4 + CD25 2 T cell proliferation ( Figure 3A  and B) . Furthermore, the suppressive activity of CD8 + CD38 high T cells is higher than the one of CD8 + CD44 high T cells ( Figure S1 ) and potentiated by an in vitro exposure to IL-15 ( Figure S2 ).
To Figure 3C , in 
high T cell to a CD8 2 PBMC ratio of 1:3. Figure 3D summarizes the suppressive assay data performed with cells obtained from four different donors. Collectively, these studies demonstrate that both human and mouse CD8 + CD38 high T cells function as suppressor T cells.
CD8
+ CD38 high T Cells Suppressive Activity Correlates with an Increased IFN-c Secretion and Requires Cell-cell Contact
To evaluate, the pro-apoptotic activity of CD8 +
CD38
high T cells, Annexin-V and propidium iodide staining of co-cultured CD4 + CD25-OTII T cells was performed after 24 h, 48 h and cells from spleens and LN were treated either with IL-15 (100 ng/mL), IL-2 (100 ng/mL), aCD3/CD28 (1 mg/mL) or left untreated (neg ctrl). 
2 T cells, IL-17 and IFN-c concentrations were strongly increased ( Figure 4B ). Unlike the CD8 +
CD122
+ regulatory T cells previously described in naive mice [7, 37] , the CD8 + CD38 high T cell subset did not secret detectable IL-10 and no evident difference in the concentrations of the pro-inflammatory cytokine IL-6 was appreciated in the co-culture supernatants analyzed (data not shown).
To clarify the origin of higher levels of IFN-c detected in supernatants from the co-culture containing CD8 + CD38 high T cells, we have performed an intracellular IFN-c staining. As shown in Figure 4C , after 48 h of co-culture 27% of CD8 +
CD38
high T cells produced IFN-c compared to 2.2% of CD8 + CD38
2 T cells. Thus, CD8
+ CD38 high T cells display higher levels of IFN-c production. Furthermore, upon addition of CD8 + CD38 high T cells alone or with DCs in the upper chamber of a transwell system, we observed that the presence of a 0.2 mM pore size transwell membrane blocked the suppressive capacity of these cells on CD4 + OTII T proliferation ( Figure 4D ). Addition of DCs to CD8 + CD38 high T cells did not rescue the suppressive activity of these cells ( Figure 4D ). Moreover, IFN-c concentrations in supernatants of transwell co-cultures containing CD8 + CD38 high T cells were reduced to control levels (pos ctrl) ( Figure 4E) . Furthermore, the presence of CD8 +
high T cells, DCs, and CD4
+ OTII T cells in the upper chamber of the transwell system led to IFN-c concentrations in the supernatants but had no effect on the CD4 + OTII T proliferation in the lower chamber ( Figure  S3 ). Finally, the addition of supernatants collected from cultures of CD8 + CD38 high T cells, DCs, and CD4 + OTII T cell did not suppress the proliferation of CD4 + OTII T cells ( Figure S3 ). Taken together, the suppressive activity of CD8 + CD38 high T cells is dependent on a cell-to-cell contact and correlates with an increase of IFN-c and IL-17 and a decrease of IL-2 levels in the cell-culture supernatants. We also observed that the exogeneous addition of high concentrations 100 ng/ml of IFN-c to the cell cocultures induced suppression of CD4 + OTII T cell proliferation (data not shown).
IFN-c, but not IL-2 and TGF-b, is Required for the CD8
+ CD38 high T Cell-induced Suppression 
CD25
2 OTII T cells. As shown in Figure 4F , CD8 + CD38 high T cells of this mouse strain are indeed unable to exert a suppressive action on CD4 + T cell proliferation. Consequently, IFN-c seems to present a critical mediator for CD8
+ CD38 high T cell-mediated suppression ( Figure 4F ). The results obtained are in agreement with a number of studies indicating the critical role of IFN-c for CD8
+ regulatory T cell activities [12, 17, 38] .
However in other studies, the suppressive activity of regulatory T cells was shown to be dependent on antiinflammatory cytokines, e.g. IL-10 and TGF-b, pro-apoptotic factors, e.g. granzyme B, and/or by sequestering activating mediators, e.g. IL-2 [39] . To examine the role of IL-2 and TGF-b in CD8 +
CD38
high T cell-mediated suppression, the coculture of CD8 + CD38 high T cells and CD4 + CD25 2 OTII T/ DCs/OVA 323-339 peptide was performed in the presence of exogenous IL-2 or TGF-b blocking antibodies ( Figure S4 ). No differences were observed in the suppressive effect of CD8 + CD38 high T cells in the presence of either added IL-2 or TFG-b blocking antibodies. Furthermore, we investigated whether the suppressive activity of CD8 +
high T cells was mediated by the release of granzyme B. As shown in supplementary Figure S4, [29] . This evidence strongly supports our findings on the role of CD38 as a marker for suppression in T cells. CD38 is both, a cell surface enzyme and a receptor. The contribution of CD38 to the regulation of T cell activation has been shown by the use of agonist anti-CD38 antibodies that mimic the natural ligand CD31 and lead to the induction of T cell proliferation, protein phosphorylation and cytokine production. The colocalization of CD38 and CD3 to the lipid rafts was shown to be essential for T cell signaling [44, 45] . Whether an active engagement of CD38 is also necessary for the suppressive activity of CD4 + and/or CD8 + T cells as described above for the control of T cell activation is yet to be defined. 
high T cells did not induce CD4 + T cells apoptosis at early time points and that their suppressive activity was also granzyme B and perforin independent but required cell-to-cell contact and IFN-c secretion. We have also shown that CD8 + CD38 high T cells from IFN-c deficient mice were not able to suppress effector T cell proliferation and we found higher concentrations of IFN-c in the supernatants of co-cultures with CD8
+ CD38 high T cells. Moreover, we demonstrated a contact-dependency of CD8 + CD38 high T cells with CD4 effector T cells for the production of IFN-c. The key role of IFN-c for suppression is in line with a recent report in which expanded CD8 + Treg cells produced IFN-c and required cell-to-cell contact to suppress CD4 + T cell proliferation. However, this is accompained by a concomitant IL-10 production that we failed to detect in our experimental settings [47] . Similar to our data, other studies show that IL-10 did not contribute to Qa-1-restricted suppression by CD122
+
CD44
+ CD8 + Treg [13] . In our study, the subpopulation of CD8 + CD38 high T cells isolated from naive mice by using CD8 + and CD38 high markers displays a memory-like phenotype which considerably overlaps with the previously described CD8 + CD122 + Tregs [15] . 
CD122
+ T cells. The CD122 receptor is considered as both, a regulatory and a memory marker in CD8 + T cells, and alone it is not sufficient to define Treg subsets [48] . Nevertheless, the CD8 +
+ cell population clearly contains T cells with regulatory properties [37] . CD8 + CD38 high T cells belong to the CD8 +
+ CD44 + regulatory population, but they differ since they do not express PD-1 and Ly-49G2 on their surface. Because CD38 defines CD25 + CD4 + Tregs with high suppressive activity [29] , and the CD38 defiency inhibits Treg development [49] , our study suggests that CD38 is a marker which further narrows the highly suppressive CD122 + CD44
The development of both, CD8 + CD122 + and CD8 + CD38 high T cells remains unclear. Despite the fact that they do exist naturally in the periphery of non-immunized mice and healthy humans, the thymic origin of these cells has not been proven, yet. Some studies suggest that CD8
+ CD122 + T cells may develop in the periphery in response to the contact with autoantigens [50, 51] . Tsai and colleagues support the hypothesis that many regulatory T cell subsets share a memory-like phenotype resulting from a previous antigenic stimulation and are needed to generate a negative feedback regulatory loop that would be able to inhibit the progression of autoimmunity or to promote the chronicity of infection or the progression of cancer [52] . Our study further supports this hypothesis suggesting that CD8 +
CD38
high T cells are a subset of memory phenotype T cells in naive mice with suppressive functions which expand and potentiate their inhibitory activity in an IL-15 rich microenvironment. Thus, these cells might be clinically potentially important by regulating selftolerance and restricting excessive immune responses.
In summary, we have described CD8
+ CD38 high T cells as potent immunosuppressive cells in vitro and in vivo, which constitute attractive potential therapeutic targets for the treatment of immune responses. Finally, we suggest that CD8
+
CD38
high T cells may function as regulatory cells that together with innate lymphoid cells operate in controlling immune homeostasis and attenuating inflammatory damage.
Materials and Methods
Mice
All mice were on a C57BL/6 background. C57BL/6j wt mice, IL-15 2/2 [49] , IL-15 tg C57BL/6 strain B1 (transgenic for IL-15) [53] , C57BL/6 OTII mice, whose transgenic CD4-TCRs specifically recognize the OVA (323-339) epitope were provided from Charles River, C57BL/6 rag1 2/2 OTI from Harlan Laboratories, ifng 2/2 (B6.129S7-Ifng tm1Ts/J ) from Jackson Laboratory, gzb 2/2 mice were obtained from the Bernhard Nocht Institute for Tropical Medicine of Hamburg. Mice were maintained at the Research Center Borstel Animal Facilities. Female mice were used between 8-12 weeks of age if not indicated otherwise and were maintained in specific pathogen-free conditions. All in vivo experiments were performed in compliance with national and institutional guidelines.
Cell Isolation and Purification
CD8
+ T cells were purified from spleens and LN (inguinal, axillar and mesenteric) of C57Bl/6j mice by immunomagnetic depletion using FITC labelled antibodies against CD4, CD11b, CD11c, B220, DX5 (all from BD Pharmingen), F4/80 antibodies (Serotec) and FITC microbeads (Miltenyi Biotec) and Auto-MACSH (Miltenyi Biotec). Negative purified CD8 + cells (.94% pure) were stained with anti-CD8 and anti-CD38 antibodies, and the CD8 
CD25
2 T cells were purified from lymph nodes of OTII mice by immunomagnetic depletion using labelled aCD8a, aCD11b, aCD11c, aB220, aDX5, aCD25 (all from BD Pharmingen), aF4/80 antibodies (Serotec) and microbeads (Miltenyi Biotec) and AutoMACSH (Miltenyi Biotec).
For the generation of bone marrow derived dendritic cells (BMDC), C57BL/6j wt mice bone marrow cells were cultivated in RPMI-1640 medium supplemented with 10% heat inactivated FCS, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Gibco ) in presence of 20 ng/ml murine recombinant GM-CSF. After one week of culture, CD11c
+ cells represented .98% of the total cells.
Cell Culture
Cells were cultured in RPMI-1640 supplemented with 10% heat inactivated FCS, 50 mM 2-mercaptoethanol, 2 mM Lglutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Gibco). In some conditions, CD8 + cells were cultured at 1610 6 cells/ml with 100 ng/mL of IL-15 (recombinant human from R&D) or IL-2 (Human IL-2 from Biotest Pharma) for 48 h or 72 h.
Immunophenotypic FACS Analysis
Cells were resuspended in FACS-buffer (2% newborn calf serum, 0.1% NaN3, 2 mM EDTA in PBS), stained with mAb against CD8a (53-6.7), CD4 (RM4-5), (DX5), CD25 (7D4), CD28 (37.51), CD38 (90), CD44 (IM7), CD45RB (16A), CD62L (MEL-14), CD69 (H1.2F3), CD95 (Jo2), CD95L (Kay-10), CD103 (M290), CD122 (TM-b1), CD152 (UC10-4F10-11), CD195 (C34-3448), GITR (DTA-1), TCR-b (H57-597), Qa-1 (6A8.6F10.1A6) (all from BD PharMingen), CD197 (4B12), CD94 (18d3), CD127 (A7R34), Ly-49G2 (4D11), NKp46 (29A1.4), PD-1 (J43), TCR-cd (eBioGL3) (eBioscience), for 20 min at 4uC and subsequently washed with 1 mg/ml propidium iodide (Sigma-Aldrich) in FACS buffer. Cells were analyzed by using a FACSCalibur flow cytometer (BD Biosciences). Intracellular FACS staining was performed according to a standard protocol from eBioscience after a surface staining. Intracellular staining after fixation and permeabilization was performed by incubation with mAb against Foxp3 (FJK-16 s), granzyme B (16G6), perforin (OMAK-D) + CD25 2 OTII cells were labeled with 3 mM CFSE (Vybrant CFDA SE Cell Tracker Kit, Molecular Probes) for 6 min at room temperature. The reaction was stopped by addition of FCS, cells were washed and proliferation was measured by FACS 3-4 days later. In order to suppress proliferation of Teff, purified CD8 + CD38 high or CD8 + CD38 2 T cells were added in a ratio 1:1, 1:2, 1:10 and 1:50 (Treg:Teff). Cells were seeded into 96-well, round-bottom microtiter plates (Nunc) in a total volume of 200 ml of RPMI-1640 supplemented with 10% heat inactivated FCS, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Gibco). Each condition was set in triplicates and maintained for 3-4 days at 37uC and 5% CO 2 . CD4 + cells were analyzed for CFSE proliferation. To prevent cell contact between Teff and CD8 + CD38 high or CD8 + CD38 2 T cells, anopore transwell membranes with a pore size of 0.2 mm (Nunc) were used. For IFN-c intracellular staining, the last 6 h of a 48 h incubation brefeldin (10 mg/mL from Sigma), ionomycin (1-m g/mL from Sigma) and PMA (100 ng/mL from Sigma) were added to the coculture.
Suppression Assay with Human CD8
+ CD38 high T Cells
All human subjects gave written consent and the protocol was approved by the ethic commission of the University of Lübeck. Whole blood was drawn from a forearm catheter and PBMC from whole blood were isolated using VacutainerH CPTT (BD Bioscience) following the manufacturer's instructions. Plasma was collected and heat inactivated for 30 min at 56uC and centrifuged at 4,500 6g for 10 min. Negative selection of CD8 + T cells was performed by applying the AutoMacsH (Miltenyi Biotec) using a CD8 + T Cell Isolation Kit (Miltenyi Biotec high T cells were incubated in 200 ml X-Vivo 15 medium (Cambrex) supplemented with 1% inactivated, autologous plasma and stimulated with 0.5 mg/ml anti-CD3 antibodies (clone Okt3, eBioscience) for 62 h. Negative controls were cultured without anti-CD3 antibodies and as positive control we stimulated 1.5610 5 CD8 2 CFSE + T cells with 0.5 mg/ml anti-CD3. T cell proliferation was analysed by gating on the CD4 + T cells and measuring CFSE dilution using flow cytometry.
Apoptosis Assay
Cells were resuspended in FACS-buffer (2% newborn calf serum, 0.1% NaN3, 2 mM EDTA in PBS), stained with fluorochrome-conjugated mAbs and then the cells were evaluated for apoptosis with the annexin V-FITC apoptosis detection kit (Bender MedSystems GmbH).
Analysis of Cytokine and Antibody Production
Cytokine measurements in culture supernatants were performed using the enzyme-linked immunosorbent assay (ELISA) for IL-2, IL-17, IFN-c, IL-6 and IL-10 (R&D Systems). 
EAE Model
Statistical Analysis
Results are presented as the mean6SEM from pooled data or as representative data of independent experiments, all of which gave comparable results. Mann-Whitney test was used to determine statistical significant differences *p,0.05, **p,0.01, ***p,0.001.
Ethics Statement
This study was carried out in strict accordance with the recommendations in the guide for the care and use of Laboratory Animals. Protocols were reviewed and approved by the ''Ministerium für Landwirtschaft, Umwelt und lä ndliche Rä ume des Landes Schleswig-Holstein'' (# V 312-72241.123-3 (38-3/09)). Experiments using human blood cells were approved by the ethics committee of the University of Lübeck. Figure S1 Comparative analysis between CD8 
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